Kazunari Yoshida, MD, PhD

Can overall response to antipsychotics be predicted by early improvements in individual symptoms among Alzheimer's disease patients? The current report analyzes the CATIE-AD phase 1 dataset in an attempt...

Placebo effects are a common obstacle in the search for Alzheimer's disease treatments. This analysis of data from the large CATIE-AD study investigates ways to screen out potential placebo...